Literature DB >> 915503

Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women.

C M Banki.   

Abstract

Cerebrospinal fluid 5-hydroxyindoleacetic acid levels were determined in 31 women with unipolar involutional depression using the probenecid technique. Values were found to be lower in depression as compared to controls, but they did not correlate with the severity of the clinical picture. Anxiety, insomnia and drug response however showed significant correlation with pretreatment 5-HIAA level. Some possible interpretations are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915503     DOI: 10.1007/bf01670278

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  35 in total

1.  Attenuation of conflict behavior with cinanserin, a serotonin antagonist: reversal of the effect with 5-hydroxytryptophan and alpha-methyltryptamine.

Authors:  I Geller; R J Hartmann; D J Croy; B Haber
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-01

2.  Abnormalities of indoleamines in affective disorders.

Authors:  A Coppen; A J Prange; P C Whybrow; R Noguera
Journal:  Arch Gen Psychiatry       Date:  1972-05

3.  5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.

Authors:  H M van Praag; J Korf; J Puite
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

4.  Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain.

Authors:  G Curzon; A R Green
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

5.  Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets.

Authors:  D S Robinson; J M Davis; A Nies; C L Ravaris; D Sylwester
Journal:  Arch Gen Psychiatry       Date:  1971-06

6.  Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

Authors:  J Korf; H M van Praag
Journal:  Psychopharmacologia       Date:  1971

7.  Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients.

Authors:  A Jori; E Dolfini; C Casati; G Argenta
Journal:  Psychopharmacologia       Date:  1975-10-14

8.  Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders.

Authors:  C M Banki
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

9.  Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid.

Authors:  B Johansson; B E Roos
Journal:  Acta Neurol Scand       Date:  1975-08       Impact factor: 3.209

10.  Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain.

Authors:  C D Wise; B D Berger; L Stein
Journal:  Science       Date:  1972-07-14       Impact factor: 47.728

View more
  4 in total

1.  Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression.

Authors:  C M Banki; G Molnar; I Fekete
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

2.  5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

Authors:  F K Goodwin; R M Post
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

3.  Ethanol, monoamines, and affect.

Authors:  C J Clayton; R E Hicks
Journal:  J Neural Transm Gen Sect       Date:  1994

4.  Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims.

Authors:  S Matsubara; R C Arora; H Y Meltzer
Journal:  J Neural Transm Gen Sect       Date:  1991
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.